SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-025657
Filing Date
2022-07-11
Accepted
2022-07-11 07:38:37
Documents
17
Period of Report
2022-07-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ny20004741x1_8k.htm   iXBRL 8-K 53709
2 EXHIBIT 2.1 ny20004741x1_ex2-1.htm EX-2.1 608739
3 EXHIBIT 10.1 ny20004741x1_ex10-1.htm EX-10.1 72645
4 EXHIBIT 99.1 ny20004741x1_ex99-1.htm EX-99.1 23303
8 ny20004741x1_ex99-1logo1.jpg GRAPHIC 7696
9 ny20004741x1_ex99-1logo2.jpg GRAPHIC 2963
  Complete submission text file 0001140361-22-025657.txt   1060498

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA inva-20220710.xsd EX-101.SCH 3911
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20220710_lab.xml EX-101.LAB 22544
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20220710_pre.xml EX-101.PRE 16034
11 EXTRACTED XBRL INSTANCE DOCUMENT ny20004741x1_8k_htm.xml XML 4226
Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30319 | Film No.: 221075892
SIC: 2834 Pharmaceutical Preparations